Aphios 
Welcome,         Profile    Billing    Logout  
 2 Products   188 Diseases  2 Products   2 Trials   60 News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
etrinabdione (EHP-101) / Emerald Health Pharmaceuticals, Aphios, Emerald Health Research
NCT04166552: Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis

Hourglass Jan 2023 - Mar 2023 : Interim results for systemic sclerosis
Suspended
2a
36
US, RoW
Patients will be randomized to receive EHP-101 or Placebo
Emerald Health Pharmaceuticals
Diffuse Cutaneous Systemic Sclerosis
07/24
10/24
CLAUDIA, NCT06774040: Evaluation of Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients With Peripheral Arterial Disease

Not yet recruiting
2
30
Europe
Etribnabdione 25 mg BID, Etribnabdione 50 mg BID
VivaCell Biotechnology España
Peripheral Arterial Disease
03/27
05/27
APH1105 / Aphios
NCT03806478: Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

Not yet recruiting
2
60
NA
APH-1105, Placebo
Aphios
Dementia, Alzheimer Disease 1, Alzheimer Disease 2, Alzheimer Disease 3
09/24
12/24
APH-1104 / Aphios
No trials found
APH-1104 less potent analog / Aphios
No trials found
APH-1104 analog / Aphios
No trials found
betulinic acid nanoformulation (APH-0202) / Aphios
No trials found
APP-401 / Aphios
No trials found
APP-069 / Aphios
No trials found
betulinic acid nanoformulation (APH-0201) / Aphios
No trials found
Dermos (paclitaxel nanosomal) / Aphios
No trials found
Camposomes (camptothecin nanosomal) / Aphios
No trials found
Taxosomes (paclitaxel nanosomal) / Aphios
No trials found
Marinus / Aphios
No trials found
APP-0205 / Aphios
No trials found
APP-309 / Aphios
No trials found
nanoTHC (dronabinol) / Aphios
No trials found
NanoCanna (cannabinoid nano) / Aphios
No trials found
oral insulin (APH-0907) / Aphios
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
etrinabdione (EHP-101) / Emerald Health Pharmaceuticals, Aphios, Emerald Health Research
NCT04166552: Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis

Hourglass Jan 2023 - Mar 2023 : Interim results for systemic sclerosis
Suspended
2a
36
US, RoW
Patients will be randomized to receive EHP-101 or Placebo
Emerald Health Pharmaceuticals
Diffuse Cutaneous Systemic Sclerosis
07/24
10/24
CLAUDIA, NCT06774040: Evaluation of Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients With Peripheral Arterial Disease

Not yet recruiting
2
30
Europe
Etribnabdione 25 mg BID, Etribnabdione 50 mg BID
VivaCell Biotechnology España
Peripheral Arterial Disease
03/27
05/27
APH1105 / Aphios
NCT03806478: Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

Not yet recruiting
2
60
NA
APH-1105, Placebo
Aphios
Dementia, Alzheimer Disease 1, Alzheimer Disease 2, Alzheimer Disease 3
09/24
12/24
APH-1104 / Aphios
No trials found
APH-1104 less potent analog / Aphios
No trials found
APH-1104 analog / Aphios
No trials found
betulinic acid nanoformulation (APH-0202) / Aphios
No trials found
APP-401 / Aphios
No trials found
APP-069 / Aphios
No trials found
betulinic acid nanoformulation (APH-0201) / Aphios
No trials found
Dermos (paclitaxel nanosomal) / Aphios
No trials found
Camposomes (camptothecin nanosomal) / Aphios
No trials found
Taxosomes (paclitaxel nanosomal) / Aphios
No trials found
Marinus / Aphios
No trials found
APP-0205 / Aphios
No trials found
APP-309 / Aphios
No trials found
nanoTHC (dronabinol) / Aphios
No trials found
NanoCanna (cannabinoid nano) / Aphios
No trials found
oral insulin (APH-0907) / Aphios
No trials found

Download Options